Short Notes Flashcards

(95 cards)

1
Q

Describe the general structure and role of PDZ domains.

A

PDZ domains are common structural motifs (~80–90 AAs) found in signalling proteins across bacteria, yeast, plants, viruses, insects, and vertebrates.
They bind to the C-terminal or internal sequences of target proteins, usually near plasma membranes, and play critical roles in assembling signal transduction complexes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the structural features of PDZ domains.

A

Each PDZ domain consists of six β-strands (βA–βF) and two α-helices (A and B), arranged in a compact globular fold.
Ligand peptides bind in an elongated groove where their β-strand aligns antiparallel to the PDZ βB strand.
Binding involves a carboxylate-binding loop between βA and βB, recognising the terminal carboxylate group of the peptide ligand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do PDZ domains recognise and bind their target sequences?

A

PDZ domains bind to the C-terminal four/five residues of target proteins, typically transmembrane receptors or ion channels (high affinity).
The consensus sequence contains a hydrophobic residue (Val or Ile) at the C-terminus, while positions –2 and –3 determine specificity.
PDZ domains may heterodimerise with other PDZ domains, facilitating regulatory IC signalling.
Some PDZ domains (sytenin, CASK, Tiam1, FAP) also bind PIP₂, linking membrane lipids to protein scaffolding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give examples of PDZ domain–containing proteins and their binding partners.

A

PSD-95 (Post-Synaptic Density Protein 95) binds:
NMDA receptor B subunit via PDZ1/PDZ2 (binding motif: –IESDV–COOH).
Kv1.4 K⁺ channel via PDZ1/PDZ2 (motif: –VETDV–COOH).
Neuronal nitric oxide synthase (nNOS) via PDZ2-PDZ interaction.
These examples illustrate PDZ-mediated scaffolding in neuronal synapses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State the main biological functions of PDZ domain proteins.

A

Maintaining epithelial cell polarity and morphology.

Organising the postsynaptic density in neurons.

Regulating trafficking and activity of membrane proteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define quaternary structure of proteins and outline its key features.

A

Quaternary structure refers to the association of two or more polypeptide chains (subunits) into a single, functional complex.
Each subunit has its own primary, secondary, and tertiary structure, but together they form an oligomeric protein.
Subunits can be identical (homomeric) or different (heteromeric) and are held by non-covalent interactions (hydrogen bonds, hydrophobic interactions, ionic bonds, van der Waals forces) and sometimes disulfide bridges.
Proper subunit arrangement is essential for biological activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain why quaternary structure is important for protein function.

A

The spatial arrangement of subunits determines cooperative and allosteric behaviour (e.g., haemoglobin’s oxygen binding).
Structural alterations in subunit interfaces can drastically change activity.
Many metabolic and signalling enzymes require conformational flexibility between subunits for regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give examples of quaternary protein types and their oligomeric states.

A

Dimers: Alcohol dehydrogenase (ADH), malate dehydrogenase (MDH).
Tetramers: Lactate dehydrogenase (LDH), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), haemoglobin (Hb).
Human LDH exists in five isoenzyme variants due to combinations of A and B subunits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the forces stabilising quaternary structure.

A

Hydrogen bonds – stabilise between polar residues.

Hydrophobic interactions – drive nonpolar side chains into the interface core.

Ionic interactions – contribute to charge complementarity.

Van der Waals forces – enhance tight packing.

Disulfide bridges – covalently link subunits, increasing structural stability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is quaternary structure experimentally determined?

A

A variety of analytical and computational methods are used:
Analytical Ultracentrifugation: Determines mass via sedimentation velocity.

Size-Exclusion Chromatography: Estimates molecular weight and subunit association.

FRET (Fluorescence Resonance Energy Transfer): Detects subunit proximity and conformational changes.

X-Ray Crystallography: Provides atomic-resolution 3D structures.

NMR Spectroscopy: Infers size via rotational correlation coefficients.

Dynamic Light Scattering (DLS): Measures hydrodynamic radii of complexes.

Bioinformatics / AI-based prediction: Programs such as AlphaFold-Multimer predict subunit interfaces computationally.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the key structural and functional features of oligomeric proteins?

A

Quaternary structures form spontaneously and rapidly once subunits contact.

The oligomeric form is more stable in aqueous environments than separate subunits.

Subunits may undergo conformational or reorientational changes (basis for allostery).

Quaternary structure is essential in cell signalling, e.g. G-protein coupled receptor (GPCR) systems involving α, β, and γ subunits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss the role of quaternary structure in G-protein–coupled signalling.

A

GPCRs interact with heterotrimeric G-proteins composed of α, β, and γ subunits.
Upon activation, the G-protein binds the receptor, triggering conformational change and downstream signalling.
This exemplifies how quaternary association underlies molecular communication and regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the quaternary structure of haemoglobin and its functional significance.

A

Haemoglobin (Hb) is a tetramer consisting of two α and two β subunits.
Each subunit contains a heme group composed of a ferrous ion (Fe²⁺) coordinated by a porphyrin ring.
The α- and β-chains each contain 7–8 α-helices (A–H), forming a compact globular fold.
Hb exists in two main conformations:
T (tense) state: Low oxygen affinity (deoxy form).
R (relaxed) state: High oxygen affinity (oxy form).
The T↔R transition explains cooperative oxygen binding.
Hb also functions in nitric oxide metabolism, pH regulation, redox balance, and metabolic reprogramming.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Differentiate between haemoglobin and myoglobin.

A

Myoglobin: Monomeric, stores oxygen in muscle.

Haemoglobin: Tetrameric, transports oxygen in blood.
Both contain heme prosthetic groups but differ in structure, subunit interaction, and cooperative binding behaviour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Outline the basic structure of immunoglobulins (Igs).

A

Immunoglobulins are Y-shaped glycoproteins composed of:
2 Heavy (H) chains and 2 Light (L) chains, linked by disulfide bonds.
Each chain has constant (C) and variable (V) domains.
Antigen-binding sites (Fab regions) lie at the variable domains’ N-termini, involving residues from both H and L chains.
Sequence diversity in variable regions determines antigen specificity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the Immunoglobulin Superfamily (IgSF)?

A

The IgSF comprises a large group of proteins that share the Ig domain structure—a β-sandwich of two sheets linked by a disulfide bridge.
Originally discovered in antibodies, these domains now appear in diverse proteins, including:

Antigen receptors and co-receptors

Cell adhesion molecules

Cytokine receptors

Antigen-presenting molecules

Intracellular muscle proteins
. They mediate cell–cell recognition and immune communication across species.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Define the Fab and Fc regions of an antibody.

A

Fab (Fragment antigen-binding): N-terminal region containing variable domains responsible for antigen recognition.

Fc (Fragment crystallisable): C-terminal constant region responsible for effector functions (e.g., complement activation, Fc receptor binding).
The Fc name derives from its crystallisable nature due to conserved sequence homology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the structural organisation of immunoglobulin domains.

A

Each Ig domain consists of two β-pleated sheets linked by a disulfide bridge between conserved cysteines.
Each domain (~110–130 amino acids; 12–13 kDa) forms a compact β-sandwich.

Light chains: 1 variable (V_L) + 1 constant (C_L) domain.

Heavy chains: 1 variable (V_H) + 3–4 constant (C_H) domains.
Constant domains hold H-chains together and mediate effector functions, while variable domains confer antigen specificity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are κ (kappa) and λ (lambda) light chains?

A

Antibody light chains exist in two types—κ and λ—defined by constant region sequence differences.
 Each antibody molecule carries only one type of light chain.
 The light chain’s N-terminal half is variable, while the C-terminal half is constant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Explain how heavy-chain differences define antibody isotypes.

A

Five classes of heavy-chain constant regions exist:
γ → IgG
α → IgA
μ → IgM
δ → IgD
ε → IgE

Each antibody contains one type of heavy chain, defining its isotype and functional properties.
IgM (pentameric) contains 10 heavy (μ) and 10 light chains linked by a joining (J) chain; others are monomers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What happens when immunoglobulins are enzymatically cleaved?

A

Papain cleavage: Produces two Fab fragments (antigen-binding) and one Fc fragment (effector).

Pepsin cleavage: Produces one F(ab′)₂ fragment retaining both antigen-binding sites but lacking Fc functions.


Clinical uses:
 Fab fragments — e.g., Digoxin immune Fab therapy.
 F(ab′)₂ fragments — antivenom treatment.
 Cleavage separates antigen recognition from immune effector activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the domain structure of immunoglobulins.

A

H and L chains contain homologous domains (~110 residues each) connected by intrachain disulfide loops (~60 residues).

L chain: V_L + C_L.

H chain: V_H + 3–4 C_H domains (CH₁–CH₄).
 Domains maintain a consistent folding pattern forming the characteristic Ig fold.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Explain the significance of variable (V) region domains.

A

V_H and V_L domains determine antigen specificity.
 Within these, three hypervariable (HV) regions, also known as complementarity-determining regions (CDRs), form the antigen-binding site.
 The intervening framework regions (FRs) provide structural support.
 CDR3 is the most variable and central to antigen recognition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the features of constant (C) region domains in immunoglobulins.

A

Constant regions exhibit limited variability within an isotype.

H-chain C regions (CH₁–CH₄) mediate effector interactions, complement fixation, and Fc receptor binding.

CH₂ and CH₃ are critical for immune signalling and transplacental antibody transfer (in IgG).

CH₄ (when present) contributes to polymerisation and secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What is the hinge region and its function in antibodies?
The hinge region links Fab and Fc portions, acting as a flexible tether rather than a rigid joint.
 Located C-terminal to CH₁, it allows independent movement of Fab arms, improving antigen accessibility.
 Encoded by separate exons, hinge flexibility is crucial for immune adaptability.
26
Describe the immunoglobulin fold.
The Ig fold is a two-layer β-sandwich consisting of 7–9 antiparallel β-strands arranged in two sheets with a Greek key topology.
 This structure forms the basis for both constant and variable domains. 
It enables loop variability for antigen binding while maintaining structural stability through disulfide bridging.
 The fold contributes to quaternary assembly by facilitating non-covalent interactions between domains on different chains.
27
quaternary structure
Quaternary structure refers to the association of multiple polypeptide chains (subunits) into a single functional protein. In haemoglobin, this structure is critical as the four subunits interact cooperatively to transport oxygen. Subunits are linked by noncovalent forces and occasionally by covalent disulfide bonds, maintaining structural and functional integrity.
28
haemoglobin
Haemoglobin (Hb) is a two-way respiratory carrier protein in red blood cells. It transports oxygen (O₂) from lungs to tissues and facilitates return transport of carbon dioxide (CO₂). Beyond gas transport, it is polyfunctional, participating in nitric oxide metabolism, pH regulation, redox balance, and metabolic reprogramming. It was first structurally resolved by Max Perutz using X-ray crystallography in 1962.
29
structural organisation of haemoglobin and myoglobin
Haemoglobin: A tetramer composed of 2 α- and 2 β-subunits, each containing a heme prosthetic group. Myoglobin: A monomeric heme protein found in muscle, functioning primarily in O₂ storage. While structurally similar in their heme-binding pockets, haemoglobin’s quaternary structure enables cooperative oxygen binding, unlike myoglobin’s hyperbolic, non-cooperative binding curve.
30
subunit composition and structure of haemoglobin
Each α-chain has 7 α-helices (A–H) and each β-chain has 8 α-helices, joined by short non-helical segments. Each subunit contains a heme group lodged between helices E and F. The heme consists of a ferrous ion (Fe²⁺) coordinated to four nitrogen atoms of the porphyrin ring and bound to a histidine residue (His F8) of the globin chain. A phenylalanine residue stabilises the heme within its pocket.
31
main types of human haemoglobins
HbA (α₂β₂): Major adult form (~97%). HbA₂ (α₂δ₂): Minor adult form (~2–3%), elevated in thalassaemia. HbF (α₂γ₂): Fetal haemoglobin, predominant in utero, has higher O₂ affinity. HbS: Sickle-cell variant (Glu→Val at position 6 of β-chain); causes polymerisation under deoxygenation. HbC: Mild hemolytic anaemia (Glu→Lys at β6). HbE, HbH, HbM: Other pathological variants with altered stability or affinity. Healthy adults mainly contain HbA and HbA₂.
32
haemoglobin binds oxygen and define the T and R states
Oxygen binds to the Fe²⁺ of the heme group, which induces conformational change in the entire protein. T (tense) state: Deoxygenated form with low O₂ affinity. R (relaxed) state: Oxygenated form with high O₂ affinity. The transition from T→R upon O₂ binding underlies cooperative binding, producing the sigmoidal oxygen dissociation curve characteristic of haemoglobin.
33
cooperative binding in haemoglobin
Cooperativity means that binding of the first O₂ molecule increases the affinity of remaining subunits for oxygen. First O₂ binding triggers conformational change in haemoglobin’s quaternary structure. This change facilitates successive O₂ binding events. The reverse applies during O₂ release — each unbinding event promotes further dissociation. This ensures efficient oxygen loading in lungs and unloading in tissues.
34
oxygen-binding behaviour of haemoglobin in lungs and tissues
In lungs, high pO₂ drives haemoglobin to rapidly bind oxygen, saturating and shifting equilibrium to the R state. In tissues, lower pO₂ and higher CO₂/H⁺ promote O₂ release as Hb shifts back to the T state. Haemoglobin delivers roughly half of its bound oxygen to tissues per circulation cycle, ensuring balance between uptake and release.
35
structural and functional features of myoglobin
Myoglobin is a monomeric, cytosolic protein in muscle tissue that stores O₂ for cellular use. It has a molecular weight of ~17 kDa and one heme group. Its O₂-binding curve is hyperbolic, indicating high affinity and lack of cooperativity. This allows myoglobin to store O₂ efficiently but makes it unsuitable for transport, as it releases O₂ only at very low partial pressures.
36
oxygen dissociation curves of haemoglobin and myoglobin
Myoglobin: Hyperbolic curve — saturates quickly, releases O₂ poorly. Haemoglobin: Sigmoidal curve — reflects cooperative binding; low affinity at low pO₂ (tissue) and high affinity at high pO₂ (lungs). This difference enables physiological O₂ transfer from haemoglobin to myoglobin in tissues.
37
Bohr effect and its physiological significance
The Bohr effect refers to the inverse relationship between pH and O₂ affinity. Increased H⁺ concentration (decreased pH) reduces haemoglobin’s affinity for O₂, promoting oxygen release to acidic tissues (e.g., active muscles). Conversely, higher pH in lungs increases affinity, favouring O₂ uptake. This effect ensures oxygen delivery matches metabolic activity.
38
carbon dioxide affects oxygen binding by haemoglobin
CO₂ acts as an allosteric effector, forming carbonic acid that dissociates into H⁺ and HCO₃⁻. Increased CO₂ shifts the O₂ dissociation curve to the right (lower affinity), enhancing O₂ release — this is part of the Bohr effect. In lungs, CO₂ is expelled, shifting the curve left, restoring higher O₂ affinity for uptake.
39
impact of carbon monoxide (CO) and temperature on haemoglobin
CO: Binds Hb with ~240× greater affinity than O₂, forming carboxyhaemoglobin. This reduces O₂ binding capacity and shifts the dissociation curve left, preventing O₂ release. Temperature: Elevated temperature (e.g., during exercise or fever) shifts the curve right, promoting O₂ unloading to tissues; cooling shifts it left, enhancing O₂ binding.
40
role of 2,3-bisphosphoglycerate (BPG) in oxygen transport
BPG binds preferentially to deoxygenated haemoglobin (T-state), reducing its O₂ affinity. It occupies a central cavity between the four subunits, crosslinking the β-chains and stabilising the T-form. This lowers O₂ affinity, facilitating oxygen release to tissues. When Hb converts to R-state upon oxygenation, the cavity collapses, expelling BPG.
41
BPG concentration change under different physiological conditions
BPG levels increase under: High altitude (low pO₂), Exercise (hypoxia), Acidemia, Increased thyroid activity. Conversely, levels decrease upon descent from altitude. Elevated BPG shifts the O₂ dissociation curve right, improving O₂ delivery to hypoxic tissues — a key adaptation to low oxygen tension.
42
haemoglobin’s interaction with allosteric effectors
Haemoglobin is an allosteric protein, meaning small molecules bind at sites distinct from the O₂-binding site, influencing affinity. Effectors include O₂, CO₂, H⁺, and BPG. BPG → negative allosteric effector (decreases affinity). CO₂ and H⁺ → stabilise T-state, promoting O₂ release (Bohr effect). O₂ binding → increases affinity of remaining subunits, reducing affinity for H⁺ and CO₂ (Haldane effect). This interdependence fine-tunes O₂ transport under varying metabolic demands.
43
Bohr and Haldane effects
Bohr effect: ↑CO₂ or ↓pH reduces O₂ affinity → promotes O₂ release. Haldane effect: O₂ binding reduces Hb’s affinity for CO₂ and H⁺ → facilitates CO₂ release in lungs. These reciprocal effects optimise gas exchange during respiration.
44
sequential (Monod–Wyman–Changeux) model of haemoglobin cooperativity
This model proposes that haemoglobin exists in equilibrium between T and R conformations. Each O₂ binding event increases the likelihood of the entire molecule adopting the R-state. Thus, O₂ affinity increases sequentially with each bound molecule, accounting for the sigmoidal binding curve.
45
What are the main types of human haemoglobin?
Human haemoglobin types include HbA, HbA₂, HbE, HbF, HbS, HbC, HbH, and HbM. HbA (α₂β₂): Main adult haemoglobin. HbA₂ (α₂δ₂): Minor adult form; elevated in thalassaemia. HbF (α₂γ₂): Fetal haemoglobin; persists in newborns; high levels (>2%) in adults may indicate pathology. HbS: Sickle cell variant (β6 Glu→Val). HbC: Mild haemolytic anaemia (β6 Glu→Lys). Healthy adults mainly have HbA and HbA₂.
46
How do haemoglobin mutations arise?
Abnormal haemoglobins result from mutations in the globin genes, involving: Base substitutions → amino acid changes (e.g., HbS β6 Glu→Val). Additions/deletions → frameshift or altered chain length. Premature stop codons → truncated chains (e.g., Hb McKees Rocks β145 Tyr→Stop). Stop codon loss → elongated chains (e.g., Hb Constant Spring α142 UAA→CAA). Rarely, mispairing or crossover during meiosis produces fusion genes.
47
What molecular effects do haemoglobin mutations have?
Amino acid substitutions can cause: Tetramer instability. Distortion of tertiary/quaternary structure. Impaired Fe³⁺ reduction (methemoglobinaemia tendency). Altered heme or 2,3-DPG binding. Defective α–β subunit contact. Such changes affect solubility, oxygen affinity, and red-cell deformability.
48
How are haemoglobin variants identified?
Historically, variants were characterised by peptide analysis (amino-acid sequencing). Modern identification uses gene sequencing and mass spectrometry. There are >500 β-chain variants and >370 α-chain variants currently documented. Unstable variants arise from sequence changes disrupting structural integrity.
49
Describe the structural change in HbS and its consequences.
HbS results from substitution of valine for glutamic acid at position 6 of the β-chain. This replaces a polar, charged residue with a hydrophobic one, creating a “sticky patch.” At low O₂, deoxy-HbS exposes Val6, which interacts hydrophobically with Phe85 and Leu88 of another Hb molecule. This promotes polymerisation into fibres, distorting erythrocytes into sickle shapes.
50
How does sickle-cell mutation affect red blood cell shape and function?
Sickle cells lose their normal deformability. Under hypoxia, polymerised HbS forms rigid fibres → sickle-shaped RBCs. Consequences: Fragile cells → haemolysis → anaemia. Blocked capillaries → vaso-occlusion, pain crises. Increased viscosity → tissue hypoxia. Normal biconcave RBCs are flexible and easily traverse microcapillaries, whereas sickled cells cannot.
51
Outline the genetics of sickle cell disease.
Sickle cell anaemia is autosomal recessive. Homozygotes (HbSS) → full disease expression. Heterozygotes (HbAS) → carriers with minimal symptoms. Each carrier couple has 25% risk of an affected child. Carriers exhibit malaria resistance (to Plasmodium falciparum) because infected RBCs are cleared more rapidly.
52
What is the molecular basis of malaria resistance in carriers of sickle-cell trait?
Carriers (HbAS) have some sickling under low O₂, which disrupts P. falciparum replication in RBCs. This confers a selective survival advantage in malaria-endemic regions — an example of balanced polymorphism. Homozygous HbSS individuals, however, experience severe disease and reduced life expectancy.
53
Summarise the major clinical symptoms of sickle-cell anaemia.
Bone, joint, and abdominal pain. Fatigue and fever. Breathlessness. Delayed growth and puberty. Jaundice or pallor. Tachycardia. Recurrent infections due to splenic damage. Symptoms result from chronic haemolysis, microvascular blockage, and tissue hypoxia.
54
Describe the pathophysiological mechanisms underlying sickle-cell crises.
Crises arise when low O₂ tension triggers HbS polymerisation: Leads to vessel occlusion and ischaemia. Increases blood viscosity and promotes stasis. Causes hypoxia-driven tissue damage. Episodes are intermittent but may lead to organ failure and infarction over time.
55
How do sickle-cell mutations influence prognosis?
Severity correlates with: Degree of hypoxia within cells. Haemoglobin concentration in erythrocytes. Presence of fetal haemoglobin (HbF) — higher HbF reduces sickling. Life expectancy averages ~42 years (males) and ~48 years (females) with treatment. Crises vary in frequency and intensity among individuals.
56
Outline laboratory diagnosis of sickle-cell disease.
Full blood count: Hb 6–8 g/dL, high reticulocyte count. Haemoglobin electrophoresis: Distinguishes HbA, HbS, HbC, HbF variants. HPLC (High-Performance Liquid Chromatography): Confirms variant identity and proportion. Peripheral smear: Shows sickled erythrocytes. Molecular tests may confirm β-globin gene mutation.
57
Describe standard treatment strategies for sickle-cell disease.
Folic acid and penicillin supplementation (prevent anaemia and infection). Opioids for vaso-occlusive pain crises. Hydroxyurea (hydroxycarbamide): Increases HbF production, reducing sickling episodes. Blood transfusions: Correct severe anaemia or acute chest syndrome. Bone-marrow transplantation: Potentially curative in children (requires HLA match). Gene therapy (approved 2023): Exagamglogene autotemcel and Lovotibeglogene autotemcel — re-express HbF or correct β-globin mutation.
58
Discuss the molecular rationale behind hydroxyurea therapy.
Hydroxyurea induces fetal haemoglobin (HbF) synthesis by reactivating γ-globin gene expression. HbF interferes with HbS polymerisation, thereby reducing crises and haemolysis. It also improves RBC hydration and decreases white-cell adhesion, lowering inflammation.
59
Explain the relationship between sickle-cell disease and malaria in evolutionary terms.
The sickle-cell mutation arose in Africa ~20,000 years ago due to selective pressure from malaria. Sickle-cell trait (heterozygous): Protective against P. falciparum infection — RBCs with HbAS resist parasite propagation. Sickle-cell disease (homozygous): Causes severe anaemia and higher malaria mortality. This illustrates heterozygote advantage: the allele persists in populations where malaria is endemic.
60
What are the main learning outcomes of this lecture?
By the end of the lecture, you should be able to: Understand the structure and function of tight junctions (TJs). Describe the claudin family of proteins as essential TJ components.
61
Describe the general architecture of epithelial and endothelial cell layers.
Epithelial and endothelial monolayers exhibit polarity, with: Apical membrane facing the lumen, containing microvilli and cilia. Basolateral membrane contacting other cells and the extracellular matrix (ECM). The ECM comprises the basement membrane and interstitial tissue with connective and stromal cells. Tight junctions form a seal between adjacent cells, maintaining selective permeability.
62
What are tight junctions, and where are they located?
Tight junctions are dynamic, multifunctional protein complexes located at the apical region of epithelial and endothelial cells. They: Seal intercellular spaces, preventing paracellular leakage of solutes, ions, and water. Regulate paracellular permeability and maintain tissue integrity. Separate apical and basolateral membrane domains, preserving cell polarity.
63
Define the main functions of tight junctions.
Create a barrier preventing solute diffusion between cells. Regulate paracellular transport across epithelial sheets. Maintain polarity by separating apical and basolateral domains. Contribute to cell signalling and tissue homeostasis.
64
What are protein domains, and how are they relevant to claudins?
Protein domains are independent structural and functional units conserved through evolution. They can fold and function independently and are often recombined in evolution to create new proteins. Claudins contain conserved domains such as PDZ-binding motifs that link to cytoskeletal scaffolds.
65
Describe the general structure and function of claudins.
Claudins are major integral membrane proteins of tight junctions, derived from Latin “claudere” = to close. There are 24 claudin isoforms (20–27 kDa), each with tissue- and development-specific expression. Each claudin is a tetraspan protein with: 4 transmembrane domains (TMD1–4) 2 extracellular loops (ECL1 ≈ 53 amino acids; ECL2 ≈ 24 amino acids) Cytoplasmic N- and C-termini The C-terminal PDZ-binding motif interacts with ZO-1, ZO-2, ZO-3, PATJ, and MUPP1, linking claudins to the actin cytoskeleton. They form tight junction strands in complex with Occludin and Junctional Adhesion Molecules (JAMs).
66
How are claudins classified and what are their main interaction partners?
Classical claudins: 1–10, 14, 15, 17, 19 — high sequence homology and conserved function. Non-classical claudins: All others, with more diverse roles. Claudins interact with Occludin, ZO proteins, and actin cytoskeleton to form and maintain TJ integrity.
67
Explain transcellular vs paracellular diffusion.
Transcellular diffusion: Small hydrophobic molecules pass through cell membranes. Paracellular diffusion: Small hydrophilic molecules move between adjacent cells through tight junctions. Claudins control paracellular ion selectivity and permeability in epithelial barriers.
68
Describe the role and significance of Claudin-1.
Key player in epidermal tight junction formation, co-localising with Occludin. Essential for blood–brain barrier (BBB) and blood–retinal barrier (BRB) integrity. Dysregulated in cancers: Overexpressed in colon tumours (Dhawan et al., 2005). Underexpressed in certain breast cancers (Tokes et al., 2005).
69
Describe the role of Claudin-2.
Forms discontinuous TJ strands when expressed alone. Co-expression with Claudin-1 promotes TJ network formation resembling epithelial TJs. Acts as a cationic pore-forming protein that reduces transepithelial electrical resistance (TEER). Critical during embryonic development and early epithelial formation.
70
What are the functions and disease associations of Claudin-3?
Frequently overexpressed in ovarian cancers, often with Claudin-4. May contribute to altered barrier properties in malignancy (Rangel et al., 2004).
71
Describe Claudin-4 and its biological importance.
Integral TJ protein that interacts with ZO-1, ZO-2, and ZO-3. Expressed in intestine, kidney, and lung. Overexpression increases TEER and enhances epithelial barrier function. Overexpressed in several carcinomas (except pancreas). CLDN4 gene deletion causes cardiovascular and cytoskeletal abnormalities in Williams–Beuren Syndrome.
72
Describe the localisation and role of Claudin-5.
Found in endothelial TJs and colonic epithelium. Co-localises with Occludin to seal intercellular space. Critical for blood–brain barrier (BBB) formation and selective permeability.
73
Describe Claudin-6 and Claudin-7.
Claudin-6: Expressed in embryonic kidney, absent in adults. Claudin-7: Investigated as a biomarker for breast and neck carcinomas. Functions as a Na⁺ channel in paracellular transport. Found in nephrons, colonic, and tonsillar epithelia.
74
What is known about Claudin-8?
Present in colonic epithelia and kidney. Reduces paracellular cation permeability. Downregulated in Crohn’s disease, contributing to barrier dysfunction.
75
Explain the biological role and therapeutic targeting of Claudin-18.2.
Found in normal gastric epithelium, exposed on tumour cell surfaces during malignant transformation. Overexpressed in gastric cancers and their metastases. Accessible extracellular loops make it a strong therapeutic target for monoclonal antibodies. Involved in tumour development and progression.
76
What is Claudiximab (IMAB362), and how does it function?
A chimeric IgG1 monoclonal antibody targeting Claudin-18.2. Produced in CHO cells; derived from a murine antibody with a human constant region. Binds Claudin-18.2 on tumour cells, inducing: Complement-dependent cytotoxicity (CDC). Antibody-dependent cell-mediated cytotoxicity (ADCC). Combined with chemotherapy, enhances T-cell infiltration and pro-inflammatory cytokine release. Phase I–II trials showed significant anti-tumour activity and improved progression-free survival in CLDN18.2⁺ gastric and GEJ cancers.
77
What is Zolbetuximab, and how does it differ from Claudiximab?
Zolbetuximab is a monoclonal antibody targeting Claudin-18.2, tested in two Phase III trials. Showed statistically significant improvements in progression-free and overall survival in patients with unresectable gastric cancer. Establishes Claudin-18.2 as a validated therapeutic target. Future therapies may include bispecific antibodies, antibody–drug conjugates, CAR-T cells, and mRNA-based platforms.
78
Summarise the role of Claudin-2 in clinical cancer research.
Clinical studies found Claudin-2 upregulated in breast cancer liver metastases. Cohort 1 (304 women) and Cohort 2 (237 women) studies confirmed high CLDN2 expression predicted: Shorter metastasis-free survival. Higher likelihood of liver metastasis. Suggests Claudin-2 as a prognostic biomarker for metastatic potential and recurrence in breast cancer.
79
Describe the cellular architecture relevant to blood–tissue barriers.
Epithelial and endothelial cells form polarised monolayers: Apical membrane: faces the lumen, contains microvilli and cilia. Basolateral membrane: interfaces with ECM and other cells. The ECM includes a basement membrane and interstitial connective tissue. Tight junctions separate apical and basolateral domains, regulating paracellular transport.
80
Define the blood–tissue barrier and list its major components.
The blood–tissue barrier is a selective permeability barrier controlling movement of ions, molecules, and cells between blood and tissues. Components: Endothelial cells joined by tight junctions. Basement membrane – provides filtration and support. Pericytes and glial/epithelial cells – regulate permeability, repair, and signalling.
81
What is the blood–brain barrier (BBB)?
The BBB is a semipermeable endothelial border separating circulating blood from the CNS extracellular fluid. Coined by Max Lewandowsky (1900). Protects neurons from toxins, pathogens, and fluctuations in plasma composition. Formed by: Endothelial cells of CNS capillaries.
82
blood–brain barrier (BBB)
The BBB is a semipermeable endothelial border separating circulating blood from the CNS extracellular fluid. Coined by Max Lewandowsky (1900). Protects neurons from toxins, pathogens, and fluctuations in plasma composition. Formed by: Endothelial cells of CNS capillaries. Astrocyte end-feet enveloping vessels. Pericytes within the basement membrane.
83
functions of the BBB
Regulates solute and ion exchange between blood and brain. Permits passive diffusion of small lipophilic molecules. Facilitates selective active transport of nutrients (e.g., glucose, amino acids). Excludes ~100% of large-molecule drugs and >98% of small-molecule drugs. Maintains CNS homeostasis and neuroprotection.
84
four main mechanisms of BBB regulation
Prevention of paracellular diffusion – via tight junctions sealing hydrophilic routes. Active transport – carrier-mediated import of essential nutrients. Efflux transport – removal of hydrophobic drugs/metabolites (e.g., P-gp, BCRP). Regulation of transendothelial migration – controlling immune cell or pathogen entry.
85
key cellular components of the BBB
Tight Junctions (TJs): Seal interendothelial gaps; limit paracellular diffusion of polar solutes. Astrocyte end-feet: Envelop capillaries; induce and maintain endothelial TJ phenotype. Endothelial cells: Lack fenestrations; exhibit extensive TJs and minimal pinocytosis. Pericytes: Embedded in basement membrane; regulate angiogenesis and endothelial differentiation.
86
tight junctions contribution to BBB selectivity
Endothelial tight junctions form a continuous seal restricting passive diffusion of proteins and ions. They maintain CNS ionic composition and electrical resistance, ensuring stable neuronal signalling.
87
challenges of the BBB for drug delivery
The BBB blocks almost all neurotherapeutics: 100% of large molecules. ~98% of small molecules. Drugs that cannot cross require direct CSF injection, nanoparticle carriers, or peptide-based transport vectors to penetrate the barrier.
88
cell markers to characterise BBB cells in vitro
CD31 (PECAM-1): Endothelial marker. α-SMA: Pericyte and smooth muscle marker. GFAP: Astrocyte marker. Iba1: Microglia marker. Cells are typically fixed with 4% paraformaldehyde before immunofluorescence staining.
89
types and purpose of in-vitro blood–tissue barrier models
In-vitro models are designed to study barrier physiology and drug permeability. Types include: 2D models: Monolayers on Transwell inserts, using primary or immortalised endothelial cells (alone or co-cultured with astrocytes/pericytes). Advantages: Cost-effective, reproducible, high-throughput, measurable barrier resistance. 3D models: Organoids or microfluidic “organ-on-chip” systems mimicking in-vivo vasculature. Advantages: Better recapitulate complex BBB microenvironment and cell–cell interactions.
90
methods to measure BBB integrity in vitro
TEER (Trans-Endothelial Electrical Resistance): Quantifies ionic resistance across endothelial monolayers. High TEER → strong barrier integrity. Methods: Electric impedance spectroscopy – suited for leaky or low-resistance models. Direct/quasi-DC methods – for microvessels or live tissue monolayers. Electrodes are typically silver. Tracer permeability assays: Assess diffusion of fluorescent or radiolabelled molecules across the BBB layer.
91
main applications of in-vitro BBB models
Drug permeability testing and screening. Studying efflux transporter function (e.g., P-gp). Investigating neuroinflammation and immune cell trafficking. Modelling neurodegenerative or cerebrovascular diseases. Nanoparticle and peptide-based drug delivery research.
92
blood–retinal barrier (BRB) and its components
The BRB forms part of the blood–ocular barrier, maintaining retinal homeostasis and protecting neural tissue. Inner BRB (iBRB): Endothelial tight junctions + pericytes + macroglial foot processes. Outer BRB (oBRB): Tight junctions between retinal pigment epithelial (RPE) cells. Together, they regulate solute and metabolite flux between retinal tissue and bloodstream.
93
role of VEGF in BRB regulation
The VEGF family includes VEGFA, VEGFB, VEGFC, VEGFD, and PlGF. Act via VEGFR1–3 receptor tyrosine kinases. VEGFR1: Endothelial, monocyte, HSC expression; binds PlGF. VEGFR2: Primary mediator of angiogenesis and vascular permeability. VEGFR3: Lymphatic endothelial expression. VEGFR2 signalling: Activates PI3K/Akt, MAPK, Src, and PLCγ/C pathways → promotes angiogenesis and permeability. Stimulates NO (nitric oxide) release via eNOS activation, inducing vasodilation and increased permeability.
94
pathophysiology of age-related macular degeneration (AMD)
Leading cause of vision loss in individuals >60 years. Early AMD: Drusen formation and pigmentary macular changes → mild vision loss. Dry AMD: Degeneration of RPE and photoreceptors. Wet (exudative) AMD: Pathological angiogenesis from choroid → sub-retinal space via Bruch’s membrane and RPE, driven by VEGF overexpression. Responsible for ~90% of AMD-related acute blindness.
95
mechanism and clinical role of anti-VEGF therapy
Anti-VEGF therapy inhibits VEGF-induced neovascularisation and vascular leakage. Common agents: Ranibizumab, Bevacizumab, Aflibercept. Mechanism: Block VEGF–VEGFR2 binding → reduce NO production, endothelial permeability, and vessel growth. Administered via intra-vitreal injection to target retinal vasculature directly. Significantly improves visual outcomes in wet AMD and diabetic retinopathy.